Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NSC606985

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
The acidic leucine-rich nuclear phosphoprotein 32 (ANP32)B has been reported to regulate gene expression by acting as a histone… Expand
2009
2009
The camptothecins, which target the intranuclear enzyme topoisomerase I, have advanced to the forefront of several areas of… Expand
2009
2009
We reported previously that NSC606985, a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells through… Expand
2009
2009
We previously reported that NSC606985, a new camptothecin analog, induces apoptosis of acute myeloid leukemic cells, which is… Expand
2009
2009
PU.1 is one of key regulators of hematopoietic cell development, a tightly-regulated lineage-specific process. Here we provide… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2008
2008
PurposeProstate cancer is a major cause of cancer mortality in American males. Once prostate cancer has metastasized, there is… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2008
2008
AbstractAim:This study was conducted to reveal new proteins involved in acute myeloid leukemia (AML) cell apoptosis.Methods:Using… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2007
2007
We reported previously that NSC606985, a camptothecin analogue, induces apoptosis of acute myeloid leukemia (AML) cells through… Expand
2007
2007
Nanomolar concentrations of NSC606985, a novel camptothecin (CPT) analog, effectively induces apoptosis in vitro in acute myeloid… Expand
Highly Cited
2005
Highly Cited
2005
As a promising new class of anticancer drugs, camptothecins have advanced to the forefront of several areas of therapeutic and… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5